MORGAN STANLEY

Holdings History for Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX)

Symbol: EWTX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$72,233,511	2,910,881	+2,041,203	+235%	$24.81	Q4 2025
30 Sep 2025	0%	+0%	$14,106,178	869,678	+141,964	+20%	$16.22	Q3 2025
30 Jun 2025	0%	+0%	$9,540,337	727,714	+318,717	+78%	$13.11	Q2 2025
31 Mar 2025	0%	-0%	$8,997,934	408,997	-27,433		$22.00	Q1 2025
31 Dec 2024	0%	+0%	$11,652,693	436,430	+18,299		$26.70	Q4 2024
30 Sep 2024	0%	+0%	$11,159,916	418,131	+168,157		$26.69	Q3 2024
30 Jun 2024	0%	-0%	$4,502,040	249,974	-124,744		$18.01	Q2 2024
31 Mar 2024	0%	+0%	$6,834,856	374,718	+149,539	+66%	$18.24	Q1 2024
31 Dec 2023	0%	+0%	$2,463,458	225,179	+152,108	+208%	$10.94	Q4 2023
30 Sep 2023	0%	-0%	$418,697	73,071	-27,322	-27%	$5.73	Q3 2023
30 Jun 2023	0%	+0%	$778,046	100,393	+36,120	+56%	$7.75	Q2 2023
31 Mar 2023	0%	+0%	$428,702	64,273	+3,972	+6.6%	$6.67	Q1 2023
31 Dec 2022	0%	-0%	$539,092	60,301	-44,432	-42%	$8.94	Q4 2022
30 Sep 2022	0%	+0%	$1,031,000	104,733	+57,862	+123%	$9.84	Q3 2022
30 Jun 2022		0%	$1,000	93	0		$10.75 ^*	Q2 2022
30 Jun 2022	0%	+0%	$373,000	46,871	+24,896	+113%	$7.96	Q2 2022
31 Mar 2022	0%	+0%	$214,000	21,975	+4,814	+28%	$9.74	Q1 2022
31 Dec 2021	0%	+0%	$262,000	17,161	+16,312	+1921%	$15.27	Q4 2021
30 Sep 2021	0%	+0%	$14,000	849	+387	+84%	$16.49	Q3 2021
30 Jun 2021	0%	+0%	$10,000	462	+462	NEW	$21.65	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.